We are excited to announce the official launch of the Global Alliance for Immune Prediction and Intervention (GLIMPRINT).
GLIMPRINT is a nonprofit organization (501 (c)(3)) that emerged from the IMAG/MSM Working Group on Multiscale Modeling and Viral Pandemics. The working group, which has grown to nearly 300 members over the last couple of years, will continue to focus on its initial mission of multiscale modeling and viral infections. GLIMPRINT’s mission focuses on the broader immune system using emerging modeling technologies, namely medical digital twins.
The Mission of GLIMPRINT is to establish a global, multidisciplinary alliance to facilitate the development and application of predictive immune system models to improve our understanding of systemic immune-related etiologies and pathologies and initiate a new era of novel therapeutic design through systems-based precision medicine. We strive to facilitate the development of technological, scientific, regulatory, and social infrastructure and its application in science, medicine, and education. We aim to be a primary resource of expertise to academia, industry, and governments in advancing our understanding of the immune system to better treat existing diseases and facilitate preparedness for future pandemics and emerging diseases.
The GLIMPRINT member community is already growing since its “soft” launch earlier this year, and we are cordially inviting you to join the community. Individual and institutional membership information is available on our website here. If you decide to join GLIMPRINT, please also fill out this questionnaire so that we can share your expertise and work with the rest of the community.
We also invite you to our biweekly webinars related to medical digital twins, multi-scale modeling, viral pandemics, and the immune system, co-organized by GLIMPRINT and the IMAG/MSM Working Group.
Thank you and please don’t hesitate to contact us with any questions.
Best wishes,
Tom Helikar & James Glazier
***The University of Nebraska E-Mail Confidentiality
Disclaimer***
The information in this e-mail may be privileged and
confidential, intended only for the use of the addressee(s)
above.
Any unauthorized use or disclosure of this information is
prohibited. If you have received this email by mistake,
please delete and immediately contact the sender.